Skip to content

Ayurvedic treatment of Ardhavabhedaka.

â??Management of Ardhavabhedaka (Migraine) with Laghu Sutashekhara Rasa and Brihat Dashmoola Taila Nasyaâ??

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/02/006598
Enrollment
100
Registered
2016-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from Ardhavabhedaka

Interventions

Intervention1: In Group A-Brihat Dashmoola Taila Nasya and Laghu Sutashekhara Rasa orally: duration-60 days for group A. Nasya 4 sittings for 7 days at the interval of 7 days Control Intervention1: In

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients in the age group 18 to 60 years, presenting with signs and symptoms of Ardhavabhedaka - Migraine described as per Ayurveda and modern science will be included in the study. 2. The diagnosis of the disease shall be done on the basis of clinical manifestations like recurrent attacks of headache, mostly unilateral in site, variable in intensity, frequency and duration with or without nausea, vomiting, aura and GI tract symptoms.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from any chronic debilitating disease, with other neurological pathology, E.N.T. pathology, stress headache and cases which required surgical intervention will be excluded from study. 2. Patients suffering from Sinusitis, Hypertension, Secondary headache caused by meningitis, tumor, encephalitis, cervical spondylitis and refractive errors will be excluded from study. 3. Patients using any other systemic drugs which may alter the results of study. 4. Patients who need psychiatric treatment will be excluded.

Design outcomes

Primary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of disease in the signs and symptoms based on the standard pattern will be applied before and after treatment.Timepoint: 60 days

Secondary

MeasureTime frame
MIDAS criteria will be applied before and after treatmentTimepoint: 60 days

Countries

India

Contacts

Public ContactDr D B Vaghela

IPGTRA GAU Jamnagar

drvaghela@rediffmail.com09825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026